Bank of America spends $250 million a year on weight loss drugs for staff: ‘We see a great impact – Fortune
Weight-loss drugs are becoming a popular employee perk, with almost a third of workers saying they’d switch jobs to get GLP-1 coverage. Now, Bank of America is spending $250 million or more yearly on the drugs for its staffers—and CEO Brian Moynihan says the upsides are well-worth the eye-watering cost. “What we see is a…
Read more



